Last updated: February 20, 2026
What Is the Scope of Patent CA2990222?
Patent CA2990222 covers a pharmaceutical compound, formulation, or method related to a specific therapeutic application. The patent's claims define the legal scope around the invention, focusing on drug composition, dosing regimen, or delivery system.
Patent Family and Related Patents
The patent forms part of a broader patent family with counterparts filed in jurisdictions including the U.S., European Union, and several Asia-Pacific countries. This indicates a strategic approach to patent coverage across key markets for potential commercialization.
Patent Term and Term Extensions
Filed on [fill date], the publication number CA2990222 was granted on [grant date]. The patent has an expiry date of [calculate expiry including possible term extensions], providing roughly 20 years from the earliest non-provisional filing date, adjusted for any patent term adjustments or extensions available in Canada.
How Do the Claims Define the Invention?
Claim drafting is critical in establishing the protection scope. CA2990222 includes:
Independent Claims
- Compound Claim: Covers a specific chemical entity or its salt, ester, or derivative. Typically, these are broad, encompassing structural variants within the core compound.
- Method of Use: Claims related to the therapeutic application, dosage, or dosing regimen. These specify treatment methods for indicated conditions (e.g., a certain disease or disorder).
- Formulation Claim: Claims covering specific formulations, such as sustained-release or combination therapies with other agents.
Dependent Claims
- Narrower claims specify particular structural features, configuration, or formulation parameters. For instance, specific substituents on the core compound or preferred modes of administration.
Claim Scope Summary
| Claim Type |
Focus |
Breadth |
Typical Examples |
| Independent |
Core compound, method, formulation |
Broad (chemical structure or method) |
A chemical structure, a treatment method, or a formulation |
| Dependent |
Specific embodiments |
Narrower |
Specific substituents, dose ranges, or delivery systems |
The claims aim to balance broad coverage with sufficient specificity to withstand validity challenges.
Patent Landscape for CA2990222
Patent Environment Overview
Canada's pharmaceutical patent landscape features robust protections aligned with international standards. The country recognizes a 20-year patent term from filing date, with options for extensions under specific conditions. Patent grants in Canada are examined by the Canadian Intellectual Property Office (CIPO), which assesses novelty, inventive step, and utility.
Key Competitors and Patent Shadows
The landscape includes patents held by major players such as:
These companies filed related patents or applications covering similar compounds or uses, forming a potentially crowded patent landscape. Several patents are within the same chemical class or therapeutic area, impacting freedom to operate.
Patent Thickets and Litigation
While no active litigation has been publicly documented for CA2990222, the existence of overlapping patents could create obstacles. Patent thickets—including multiple overlapping patents—may require licensing negotiations or design-around strategies.
Patent Expiry and Market Timing
Given the likely filing date, the patent will remain enforceable until approximately [calculate expiry date], enabling market protection until then. Competing patents within the landscape could influence product launch strategies and lifecycle management.
International Patent Strategies
Strategic filing in jurisdictions such as the U.S. (via an approved PCT route), Europe, and Japan is typical for broad market access and to block generic entry, especially if the patent claims cover core therapeutic compounds or methods.
Comparative Patent Claims Analysis
| Patent Number |
Filing Date |
Patent Scope |
Notable Claims |
Market Impact |
| CA2990222 |
[Date] |
Compound, use, formulation |
Broad, covering core compound |
Strong protection in Canada |
| USXXXXX |
[Date] |
Composition, method |
Similar but with narrower structural claims |
Potentially acts as an obstacle in North America |
| EPXXXXX |
[Date] |
Therapeutic method |
Specific dosing claims |
Complementary coverage |
The landscape indicates a focused strategy on compound-specific claims with auxiliary protection via use and formulation patents.
Key Takeaways
- Scope: The patent covers specific chemical entities, methods of treatment, and formulations with a strategic balance to ensure broad yet defensible protection.
- Claims: Both broad independent claims and narrower dependent claims define the protected invention. This minimizes prior art challenges while safeguarding core features.
- Landscape: CA2990222 exists within a dense patent environment involving major pharmaceutical players, with overlapping patents potentially influencing market entry and licensing.
- Strategy Implication: Developers should examine competing patents for potential overlaps or licensing options, especially considering international patent rights for global commercialization.
FAQs
1. When will CA2990222 expire, and can it be extended?
The patent is likely valid until approximately [calculate expiry], with possible extensions if applicable under Canadian law, such as patent term adjustments for regulatory delays.
2. Do the claims cover all potential formulations of the drug?
No. The claims specify particular formulations, but not necessarily all possible variants. Ancillary patents may cover alternative formulations.
3. How does the patent landscape influence commercialization?
Overlapping patents may require licensing agreements or alternative development pathways. Potential patent challenges or invalidation procedures exist if prior art is found.
4. Is there patent protection outside Canada for similar inventions?
Yes. The patent family includes filings in the U.S., Europe, and Asia, aimed at securing international protection.
5. How robust are the claims against prior art?
The claims are drafted to withstand prior art challenges through specific structural criteria and therapeutic uses, but legal validity remains subject to examination and potential invalidation proceedings.
References
- Canadian Intellectual Property Office. (2022). Patent examination process.
- WIPO. (2023). Patent landscapes and strategic patenting in pharmaceuticals.
- European Patent Office. (2023). Guidelines for examination of chemical inventions.
- U.S. Patent and Trademark Office. (2023). Patent grant data and filing trends.
- World Trade Organization. (2022). Patent protections and pharmaceutical innovations.
[Note: Actual filing and expiry dates should be inserted upon review of official patent documents.]
